The UNMC College of Medicine received grant and funding awards representing more than $2.6 million in new funding in October.
Ken Bayles, PhD, pathology, microbiology and immunology, received a $607,757 grant from National Strategic Research Institute for medical countermeasure drug discovery and development (increment 3).
Babu Guda, PhD, genetics, cell biology and anatomy, received a $292,104 grant from Wichita State University for “The Aging Pituitary/Gonadal Axis – Core C – Bioinformatics and Genomics Core.”
Harshraj Leuva, MBBS, internal medicine-hematology/oncology, received $239,998 for the “Robert A. Winn Diversity in Clinical Trials: Career Development Award.”
Bryant England, MD, PhD, internal medicine-rheumatology, received a grant of $104,953 from Brigham & Women’s Hospital, for SAIL-RA.
Erin Barrett, MD, dermatology, received a $70,646 grant from the University of Southern California for evaluating the PD-1 checkpoint inhibitor, Cemiplimab, as neoadjuvant therapy in high risk localized, locally recurrent, and regionally advanced cutaneous squamous cell carcinoma.
Ted Mikuls, MD, internal medicine-rheumatology, received a grant of $56, 251 from the University of Pennsylvania for “Guselkumab vs Golimumab in PsA TNF inadequate responder patients: a pragmatic trial.”
Steven Yeh, MD, ophthalmology and visual sciences, received a $19,705 grant from Cincinnati Children’s Hospital Medical Center for a study on optimizing methotrexate use for the management of chronic pediatric non-infectious uveitis.
Cyrus Desouza, MBBS, internal medicine-DEM, received a grant of $14,756 from the Nebraska Educational Biomedical Research Association to support effort on VA research projects.
Sara Bares, MD, internal medicine-infectious diseases, received a grant of $9,999 from the University of California-Los Angeles for “AIDS Clinical Trials Group for Research on Therapeutics for HIV and Related Infections.”
Vinai Thomas, PhD, pathology, microbiology and immunology, received a grant of $6,633 from the University of Virginia for “Systems biology approach to elucidate complex metabolic dependencies in the evolution of antibiotic resistance.”
Industry-sponsored grants and contracts:
Christopher Conrady, MD, PhD, ophthalmology and visual sciences, received funding to investigate the efficact, safety, pharmacokinetics and pharmacodynamics of RO7200220 administered intravitreally in patients with uveitic macular edema.
Natalia Castillo Almeida, MD, internal medicine-infectious diseases, received funding to evaluate the safety and neutralizing activity of AZD5156/AZD3152 for pre-exposure prophylaxis of COVID-19 in participants with conditions causing immune impairment.
Sara Bares, MD, internal medicine-infectious diseases, received funding for study evaluating the efficacy, safety, implementation effectiveness, and patient-reported outcomes of oral dolutegravir/lamivudine once-daily.
Soonjo Hwang, MD, psychiatry, received funding for the AI Voucher Project.
Sarah Lonowski, MD, dermatology, received funding for a study of nail and scalp psoriasis improvement in patients treated with Ixekizumab.
Hani Haider, PhD, orthopaedic surgery, received funding for a work order: Impingement testing of the Ortho Development Legend Liner with a Worst Case Hip Stem.
Matthew Lunning, DO, internal medicine-oncology/hematology, received funding for a study for the treatment of patients with commercially out-of-specification Axicabtagene Ciloleucel.